REG.AX · ASX · Healthcare
Regis Healthcare Limited
Also onShortfallConsensus DriftCrosscheck
Implied value per share
AUD -25.36
Market price
AUD 4.71
Implied upside
-638.4%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (AUD). Outflows negative.
| Line | FY27 | FY28 | FY29 | FY30 | FY31 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | AUD 2.0bn | AUD 3.0bn | AUD 4.6bn | AUD 6.8bn | AUD 10.3bn | +50.0% |
| EBIT | AUD -1.4bn | AUD -2.0bn | AUD -3.1bn | AUD -4.6bn | AUD -6.9bn | -50.0% |
| NOPAT | AUD -952.9m | AUD -1.4bn | AUD -2.1bn | AUD -3.2bn | AUD -4.8bn | -50.0% |
| Add depreciation & amortisation | AUD 384.1m | AUD 576.1m | AUD 864.2m | AUD 1.3bn | AUD 1.9bn | +50.0% |
| Less capital expenditure | AUD -241.1m | AUD -361.6m | AUD -542.4m | AUD -813.5m | AUD -1.2bn | +50.0% |
| Less increase in working capital | AUD -9.9m | AUD -14.9m | AUD -22.3m | AUD -33.5m | AUD -50.2m | +50.0% |
| Free cashflow to firm | AUD -819.8m | AUD -1.2bn | AUD -1.8bn | AUD -2.8bn | AUD -4.2bn | -50.0% |
| Discount factor | 0.9509 | 0.8597 | 0.7773 | 0.7028 | 0.6355 | - |
| Present value | AUD -779.6m | AUD -1.1bn | AUD -1.4bn | AUD -1.9bn | AUD -2.6bn | -35.6% |
| Present Value Of The Forecast | AUD -7.9bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.35% | Australian Government 10-year (RBA F2) |
| Equity risk premium | 6.00% | Market assumption |
| Beta | 0.878 | Reported 0.818, pulled toward 1.0 (Blume) |
| Cost of equity | 10.62% | Risk-free + beta x equity risk premium |
| Cost of debt | 7.35% | Implied cost of debt of 3578.9% is not a credible funding cost, so risk-free + 2bp is assumed instead. Interest expense and reported debt are measuring different things - common for banks, whose interest expense includes deposits that total debt excludes. |
| Market capitalisation | AUD 1.4bn | 99.7% of capital |
| Total debt | AUD 4.0m | 0.3% of capital, book value as a proxy |
| Tax rate | 30.0% | Effective, capped at statutory |
| WACC | 10.60% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
0% of EV
- Terminal value, undiscounted
- AUD 0.00
- Terminal value, discounted
- AUD 0.00
- Enterprise value
- AUD -7.9bn
- Less net debt
- AUD -169.8m
- Equity value
- AUD -7.7bn
Exit at 11.0x EBITDA
81% of EV
- Terminal value, undiscounted
- AUD -54.4bn
- Terminal value, discounted
- AUD -34.6bn
- Enterprise value
- AUD -42.4bn
- Less net debt
- AUD -169.8m
- Equity value
- AUD -42.2bn
Sensitivity
Value per share (AUD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 8.60% | -26.87 | -26.87 | -26.87 | -26.87 | -26.87 |
| 9.60% | -26.10 | -26.10 | -26.10 | -26.10 | -26.10 |
| 10.60% | -25.36 | -25.36 | -25.36 | -25.36 | -25.36 |
| 11.60% | -24.65 | -24.65 | -24.65 | -24.65 | -24.65 |
| 12.60% | -23.97 | -23.97 | -23.97 | -23.97 | -23.97 |
Outlined: this model. Green text: above today's price of 4.71. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| EBIT margin | -67.2% | -0.1% | +67.1pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.